The Optical Q™ is a cutting edge POC in-vitro diagnostics fluorescence immunoassay analyzer that accurately measures the concentration of analytes contained in blood, serum, plasma, and other samples.
-- Easy and simple (3 steps: dilution, drop, analysis) -- Instantaneous results (results within a few minutes) -- Top sensitivity and specificity (Immunofluorescence technology) -- Wide variety of tests (Inflammation, diabetes, vitamin D and 25 more test)
OptiBio is a biotechnology company focused in researching, developing, and creating cutting edge fluorescence immunoassay solutions. In 2019, Optibio was selected by a research fund sponsored by the Bill & Melinda Gates foundation for its unique and dedicated approach in product development. OptiBio's approach comprises of specialized teams of scientists and engineers dedicated to directly developing diagnostic markers, test kits, and analyzers, uniquely positioning OptiBio to optimize top solutions in point-of-care testing (POCT).